Is Euros Hartley paid by the company for coverage or have they initiated coverage by themselves (ie not paid by the company)? Can’t recall which brokerage has been paid and which one(s) have been.
DXB management has certainly hit some targets and the stock has de-risked; but the stock has rallied hard and remains a non-revenue generating (aside from R&D rebates) for the next year, in a difficult environment for biotechs. Worth keeping an eye out for downside risks; worthwhile not totally ruling CRs out. Not sure a CR at these prices is a totally bad idea either. Still DXB has been very impressive and lack of insto ownership might mean the SP could further strengthen.
DXB Media thread., page-174
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.060(9.84%) |
Mkt cap ! $302.3M | |||
| Open | High | Low | Value | Volume |
| 60.5¢ | 61.0¢ | 55.0¢ | $2.309M | 4.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 137019 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.5¢ | 22500 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |